Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2551]

Researchers pinpoint tumour-related protein, slow progression of cancers

Researchers pinpoint tumour-related protein, slow progression of cancers

Precise decoding of breast cancer cells creates new option for treatment

Precise decoding of breast cancer cells creates new option for treatment

FDA expands pembrolizumab indication for first-line treatment of NSCLC

FDA expands pembrolizumab indication for first-line treatment of NSCLC

ELCC 2019: Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer

ELCC 2019: Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer

New cancer drug targets accelerate path to precision medicine

New cancer drug targets accelerate path to precision medicine

ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

Single-cell sequencing reveals landscape of immune cell subtypes in lung cancer tumours

Single-cell sequencing reveals landscape of immune cell subtypes in lung cancer tumours

High-dose stereotactic body radiotherapy well-tolerated by patients with centrally located lung tumours

High-dose stereotactic body radiotherapy well-tolerated by patients with centrally located lung tumours

AACR 2019: Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer

AACR 2019: Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer

AACR 2019: Two KEYNOTE trials show pembrolizumab benefit for advanced SCLC

AACR 2019: Two KEYNOTE trials show pembrolizumab benefit for advanced SCLC

More from ecancer